21/12/2014 18:55:44 Free Membership Login

   

Accentia Pharmaceuticals, Inc.

Visual Financials
Company Name: Accentia Pharmaceuticals, Inc.
Ticker Symbol: ABPI
WWW Address: www.accentia.net
CEO: Dr. Francis E. O'Donnell, Jr., M.D.
No. of Employees: 140
Common Issue Type: CS
Business Description:A biopharmaceutical company focused on the development and commercialization of late-stage, targeted therapeutic clinical products.

 
Industry Information: DRUGS - Biotechnology [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 0.0034 Down -0.0001 0.0034 0.0048 0.0034 0.00 0.00 44500
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 0.3 89.8 0.00 -0.05 0.00 0.0 0.0 0.03 - 0.00
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close0.00$
PE Ratio - LTM0.0
Market Capitalisation0.3mil
Latest Shares Outstanding89.8mil
Earnings pS (EPS)-0.05$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee$
Effective Tax Rate%
Float84.0mil
Float as % of Shares Outstanding0.9%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue1.90%
Research & Devlopment (R&D) as % of Revenue1.30%
Gross Profit Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Assets Turnover0.0%
Return on Assets (ROA)0.0%
Return on Equity (ROE)0.0%
Return on Capital Invested (ROCI)0.0%
Current Ratio
Leverage Ratio (Assets/Equity)
Interest Cover
Total Debt/Equity (Gearing Ratio)
LT Debt/Total Capital0.0%
Working Capital pS-0.61$
Cash pS0.00$
Book-Value pS-0.76$
Tangible Book-Value pS-0.70$
Cash Flow pS-0.07$
Free Cash Flow pS-0.07$
KEY FIGURES (LTM): Price info
Price/Book Ratio0.00
Price/Tangible Book Ratio0.00
Price/Cash Flow0.0
Price/Free Cash Flow0.0
P/E as % of Industry Group0.0%
P/E as % of Sector Segment0.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---0.010.0130-5
4 Weeks0.000.000.000.010.01133
13 Weeks0.000.00445000.000.03133
26 Weeks445000.010.010.000.03-22
52 Weeks0.000.000.000.030.00-22
YTD0.000.00-0.030.0040
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
0.000.000.000.000.030.200.20
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue217353819096111909611
Income2173538217353821610175
Dividend216101752872399328723993
Capital Spending39957148NA39957148
R&D2029994NA2029994
Normalized Inc.21610175NA21610175
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %-31-61-61
Earnings %-8-817
EPS %191919
EPS $171414
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio-600.00
Current Ratio2584076
Quick Ratio (Acid Test)1579692
Liquidity Ratio (Cash)0.00
Receivables Turnover
Average Collection Period
Working Capital/Equity
Working Capital pS
Cash-Flow pS
Free Cash-Flow pS-63128744
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio431,954,535.00
Financial Leverage Ratio (Assets/Equity)1176228
Debt Ratio82320684
Total Debt/Equity (Gearing Ratio)
LT Debt/Equity3471224
LT Debt/Capital Invested0.0
LT Debt/Total Liabilities82320684
Interest Cover-2139236
Interest/Capital Invested13,089,535,000.00
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio-200.00
Current P/E Ratio - LTM28,733,993.00
Enterprise Value (EV)/EBITDA-2.40
Enterprise Value (EV)/Free Cash Flow40,544,008.54
Dividend Yield294491
Price/Tangible Book Ratio - LTM42
Price/Book Ratio - LTM161402
Price/Cash Flow Ratio
Price/Free Cash Flow Ratio - LTM42
Price/Sales Ratio-28.00
P/E Ratio (1 month ago) - LTM28733993
P/E Ratio (26 weeks ago) - LTM32883630
P/E Ratio (52 weeks ago) - LTM32883630
5-Y High P/E Ratio40027708
5-Y Low P/E Ratio36165432
5-Y Average P/E Ratio178711
Current P/E Ratio as % of 5-Y Average P/E178711
P/E as % of Industry Group108,676.0
P/E as % of Sector Segment108,676.0
Current 12 Month Normalized P/E Ratio - LTM173,601.0
PER SHARE FIGURES
LT Debt pS
Current Liabilities pS
Tangible Book Value pS - LTM
Book Value pS - LTM161402
Capital Invested pS0.00
Cash pS - LTM202
Cash Flow pS - LTM1.74
Free Cash Flow pS - LTM1.74
Earnings pS (EPS)-100
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin0.00
Free Cash Flow Margin 5YEAR AVG0.00
Net Profit Margin-2139236
Net Profit Margin - 5YEAR AVRG.2013-01-31
Equity Productivity0.00
Return on Equity (ROE)-63128744
Return on Equity (ROE) - 5YEAR AVRG.305170
Capital Invested Productivity0.00
Return on Capital Invested (ROCI)
Return on Capital Invested (ROCI) - 5YEAR AVRG.1229
Assets Productivity1,176,228.00
Return on Assets (ROA)
Return on Assets (ROA) - 5YEAR AVRG.305170
Gross Profit Margin108676
Gross Profit Margin - 5YEAR AVRG.1229
EBITDA Margin - LTM337658
EBIT Margin - LTM108676
Pre-Tax Profit Margin965163
Pre-Tax Profit Margin - 5YEAR AVRG.89755901
Effective Tax Rate100.0
Effective Tax Rate - 5YEAR AVRG.100.0
EFFICIENCY RATIOS
Cash Conversion Cycle55,971,664
Revenue per Employee
Net Income per Employee4,406
Average Collection Period
Receivables Turnover
Day's Inventory Turnover Ratio55964464
Inventory Turnover
Inventory/Sales
Accounts Payble/Sales0.00
Assets/Revenue0.00
Net Working Capital Turnover0.00
Fixed Assets Turnover0.00
Total Assets Turnover1176228
Revenue per $ Cash5813923
Revenue per $ Plant5813923
Revenue per $ Common Equity
Revenue per $ Capital Invested
Selling, General & Adm/tive (SG&A) as % of Revenue
SG&A Expense as % of Revenue - 5YEAR AVRG.89755901
Research & Devlopment (R&D) as % of Revenue
R&D Expense as % of Revenue - 5YEAR AVRG.

  


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us usotc abpi141221 18:55